two
small
piec
human
lung
tissu
surgic
implant
separ
site
back
immunodefici
mice
creat
human
lungonli
mice
lom
time
implant
tissu
expand
fig
bmode
ultrasound
imag
establish
presenc
welldefin
implant
mean
volum
fig
c
acoust
reveal
angiogenesi
format
larg
blood
vessel
fig
left
panel
vasculatur
also
observ
within
human
lung
implant
fig
right
panel
fig
supplementari
video
show
reconstruct
implant
illustr
structur
extens
vasculatur
final
surgic
excis
human
lung
implant
reveal
welldefin
structur
intern
vasculatur
fig
even
though
lung
implant
ectop
ventil
observ
structur
characterist
human
lung
includ
airway
ciliat
epithelium
alveolar
structur
cartilag
associ
blood
vessel
fig
observ
cartilagin
bronchial
noncartilagin
bronchiolar
airway
line
ciliat
airway
epithelium
fig
prealveolar
sac
also
present
fig
presenc
human
epitheli
endotheli
mesenchym
cell
also
confirm
fig
club
cell
noncili
secretori
epitheli
cell
also
present
fig
stain
mucu
secret
reveal
presenc
mucinsecret
human
globlet
epitheli
cell
fig
ex
vivo
cultur
lung
implant
cell
lp
demonstr
capac
produc
human
cytokin
chemokin
supplementari
tabl
analysi
human
donor
match
lung
tissu
time
implant
two
month
postimplant
indic
contin
human
lung
tissu
develop
prealveolar
sac
expand
flatten
cubodi
shape
epitheli
cell
could
observ
alveoli
indic
type
type
ii
pneumocyt
respect
supplementari
fig
although
observ
lung
tissu
time
implant
club
cell
readili
detect
two
month
later
fig
supplementari
fig
ciliat
epitheli
cell
abund
supplementari
fig
consist
report
subcutan
implant
human
tissu
eg
synovi
tissu
bone
vasculatur
within
human
lung
implant
primarili
human
origin
fig
mous
endotheli
epitheli
cell
readili
detect
supplementari
fig
hematopoiet
cell
murin
human
could
detect
human
lung
implant
supplementari
fig
summari
implant
human
lung
tissu
back
immunodefici
mice
result
develop
welldefin
wellvascular
easili
access
human
lung
implant
structur
resembl
present
human
lung
tissu
compos
almost
entir
human
cell
merscov
emerg
human
pathogen
target
human
infect
mice
ferret
hamster
due
genet
differ
receptor
dipeptidyl
peptidas
merscov
inocul
directli
human
lung
implant
lom
merscov
titer
mean
sem
pfumlg
rang
pfumlg
human
lung
implant
h
later
higher
inoculum
fig
presenc
merscov
antigen
human
epitheli
endotheli
mesenchym
cell
indic
merscov
broad
cellular
tropism
vivo
fig
lower
inoculum
pfu
merscov
replic
variabl
still
readili
detect
mean
sem
pfumlg
pfumlg
fig
zikv
detect
human
neonat
lung
shown
infect
human
lung
cell
line
wildtyp
mice
type
interferon
respons
suppress
zikv
human
lung
implant
lom
inocul
zikv
assay
h
later
contain
robust
level
cellassoci
zikvrna
mean
sem
zikvrna
cell
rang
zikvrna
cell
fig
zikv
antigen
detect
human
epitheli
mesenchym
cell
fig
similar
merscov
lower
inoculum
ffu
zikvrna
level
variabl
readili
detect
mean
sem
zikvrna
cell
rang
zikvrna
cell
fig
inocul
mycobacterium
bovi
bacillu
bcg
attenu
live
vaccin
strain
mycobacterium
tuberculosi
mtb
human
lung
implant
lom
bacteri
burden
assess
coloni
format
coloni
form
unit
cfu
bcg
level
human
lung
implant
lom
day
postexposur
mean
sem
cfu
rang
cfu
higher
inoculum
cfu
fig
bcg
also
replic
human
lung
implant
lom
receiv
lower
inoculum
cfu
bacteri
burden
mean
sem
cfu
rang
cfu
higher
inoculum
acidfast
stain
confirm
diffus
cluster
bacteria
within
human
lung
implant
fig
inocul
lom
implant
rsv
express
green
fluoresc
protein
gfp
day
post
rsv
inocul
gfpposit
cell
indic
rsv
infect
replic
detect
human
lung
implant
mean
sem
gfp
total
cell
rang
gfp
total
cell
fig
infect
human
airway
epitheli
cell
vitro
vivo
rsv
character
extrus
infect
cell
airway
lumen
loss
cilia
infect
ciliat
consist
observ
rsvinfect
cell
observ
protrud
shed
epitheli
cell
layer
lumen
fig
lack
costain
cilia
fig
larg
deposit
mucin
also
note
airway
rsvinfect
lung
implant
fig
observ
lung
rsvinfect
hcmv
ubiquit
humanspecif
pathogen
replic
inject
cellfre
hcmv
clinic
hcmv
strain
human
lung
implant
lom
hcmvdna
detect
lung
implant
lom
earli
day
post
inocul
mean
sem
hcmvdna
cell
rang
hcmvdna
cell
fig
hcmv
immedi
earli
ie
earli
e
late
l
protein
detect
lung
implant
day
postinocul
indic
hcmv
infect
maintain
time
fig
express
ie
protein
consist
lytic
hcmv
replic
model
observ
human
primari
infect
vivo
hcmv
antigen
observ
human
mesenchym
cell
fig
determin
effect
preexposur
prophylaxi
ganciclovir
gcv
hcmv
replic
lom
gcv
administ
daili
two
day
prior
day
inocul
hcmv
express
luciferas
fig
hcmv
replic
monitor
time
measur
luciferas
activ
four
day
postexposur
hcmv
level
lower
human
lung
implant
gcvtreat
lom
mean
sem
radianc
compar
untreat
control
mean
sem
radianc
fig
hcmv
level
continu
declin
time
gcvtreat
lom
end
gcv
treatment
cours
day
post
hcmv
exposur
hcmv
level
log
lower
lung
implant
gcvtreat
lom
mean
sem
radianc
compar
untreat
lom
mean
sem
radianc
fig
suprisingli
gcv
treatment
discontinu
hcmv
level
continu
declin
day
post
hcmvexposur
day
last
gcv
dose
hcmv
level
lung
implant
gcvtreat
lom
reduc
mean
sem
radianc
significantli
lower
untreat
control
mean
sem
radianc
fig
togeth
result
demonstr
abil
lom
sustain
replic
sever
clinic
relev
human
pathogen
serv
platform
vivo
test
exist
novel
antimicrobi
healthi
individu
hcmv
establish
lifelong
latent
infect
immun
suppress
individu
transplant
aid
patient
hcmv
reactiv
result
uncontrol
lytic
replic
caus
multiorgan
cmv
therefor
novel
antivir
need
inhibit
hcmv
lytic
replic
vivo
amelior
clinic
symptom
cmv
diseas
sinc
natur
infect
typic
asymptomat
undiagnos
profil
hcmv
gene
express
lytic
replic
vivo
determin
genomewid
scale
due
difficulti
obtain
acut
infect
sampl
defin
complement
hcmv
gene
express
human
tissu
vivo
inject
cellfre
hcmv
human
lung
implant
lom
hcmv
ds
cdna
enrich
biotinyl
probe
span
strand
entir
hcmv
genom
next
gener
sequenc
use
measur
viral
gene
express
use
novel
approach
abl
measur
first
time
complement
viral
gene
express
vivo
human
tissu
lytic
replic
result
reveal
widespread
hcmv
gene
express
span
viral
genom
consist
robust
lytic
replic
supplementari
fig
express
known
lytic
gene
encod
ie
protein
earli
protein
late
protein
detect
contrast
express
wellcharacter
latenc
gene
observ
result
serv
proofofprincipl
util
lom
investig
key
aspect
hcmv
replic
human
lung
tissu
vivo
gener
new
vivo
model
human
lung
implant
autolog
human
immun
system
construct
blt
mice
autolog
human
lung
implant
bltl
human
mice
bltl
mice
construct
surgic
implant
autolog
human
thymu
liver
tissu
kidney
capsul
human
lung
tissu
subcutan
back
precondit
irradi
immunodefici
mous
follow
bone
marrow
transplant
autolog
human
hematopoiet
stem
cell
fig
time
bltl
mice
develop
human
lung
implant
robust
level
human
hematopoiet
cell
peripher
blood
pb
sustain
least
month
last
time
analyz
fig
pb
bltl
mice
reconstitut
human
myeloid
cell
b
cell
cell
includ
cell
supplementari
fig
addit
human
epitheli
endotheli
mesenchym
cell
fig
human
lung
implant
bltl
mice
contain
human
innat
adapt
immun
cell
fig
ex
vivo
stimul
cell
pmaionomycin
lp
demonstr
broad
capac
human
cytokin
proinflammatori
antiinflammatori
chemokin
product
supplementari
tabl
human
hematopoiet
cell
present
human
lung
implant
bltl
mice
mean
sem
rang
includ
human
myeloid
cell
mean
sem
rang
b
cell
mean
sem
rang
cell
mean
sem
rang
fig
signific
differ
human
myeloid
cell
b
cell
cell
level
observ
human
lung
implant
mous
lung
bltl
mice
supplementari
fig
human
cell
present
human
lung
implant
bltl
mice
human
cell
level
significantli
lower
cell
level
significantli
higher
human
lung
implant
bltl
mice
compar
mous
lung
cell
ratio
mean
sem
rang
human
lung
implant
fig
similar
observ
differ
cell
activ
observ
supplementari
fig
memori
cell
present
human
lung
implant
bltl
mice
major
express
effector
memori
phenotyp
cell
mean
sem
rang
cell
mean
sem
rang
supplementari
fig
b
also
identifi
presenc
mean
sem
rang
memori
cell
mean
sem
rang
memori
cell
tissueresid
memori
cell
trm
human
lung
implant
bltl
mice
observ
human
supplementari
fig
like
blt
mice
addit
human
lung
implant
human
hematopoiet
cell
system
distribut
throughout
anim
includ
primari
secondari
immun
tissu
bone
marrow
human
thymic
implant
spleen
lymph
node
effector
site
mucos
tissu
lung
liver
gastrointestin
gi
tract
femal
reproduct
tract
frt
bltl
mice
fig
innat
adapt
human
immun
cell
present
tissu
analyz
supplementari
fig
lom
bltl
mice
inocul
hcmv
express
hcmv
replic
detect
human
lung
implant
lom
bltl
mice
day
postinocul
fig
lom
robust
hcmv
replic
maintain
week
postinocul
last
time
point
analyz
fig
contrast
bltl
mice
viru
replic
began
declin
day
postinocul
fig
luciferas
activ
bltl
mice
significantli
lower
compar
lom
fig
hcmv
replic
bltl
mice
continu
declin
time
fig
specif
luciferas
activ
human
lung
implant
bltl
mice
week
mean
sem
radianc
rang
radianc
week
mean
sem
radianc
rang
radianc
postinocul
approach
baselin
level
mean
radianc
significantli
lower
compar
lom
fig
result
demonstr
human
lung
implant
lom
bltl
mice
support
hcmv
infect
contrast
lom
hcmv
replic
effici
control
bltl
mice
level
human
cytokin
chemokin
analyz
bltl
mice
pre
post
hcmv
inocul
day
post
inocul
increas
plasma
level
human
gmcsf
mdc
gro
detect
supplementari
fig
hcmvspecif
human
antibodi
cell
respons
examin
bltl
mice
expos
three
differ
hcmv
strain
wellcharacter
fibroblastadapt
laboratori
strain
lack
gene
deriv
pb
plasma
collect
longitudin
measur
hcmvspecif
igm
level
hcmv
igm
level
human
peak
one
three
month
primari
consist
human
infect
hcmv
igm
detect
earli
day
follow
inocul
differ
bltl
cohort
ie
mice
gener
differ
human
donor
tissu
fig
supplementari
tabl
examin
whether
bltl
mice
induc
cell
respons
hcmv
immunopreval
human
infect
bltl
donor
tissu
hlatyp
supplementari
tabl
reactiv
hcmv
pentam
examin
hcmv
infect
induc
classic
hla
iarestrict
hcmv
cell
human
lung
implant
earli
day
follow
hcmv
inocul
fig
supplementari
tabl
function
cell
also
examin
hcmv
pentam
overlay
cell
mononuclear
cell
pool
liver
mice
cohort
b
stimul
mitogen
fig
hcmv
pentamerreact
cell
red
event
fig
right
panel
function
produc
antivir
cytokin
lytic
granul
marker
addit
function
studi
perform
use
either
ex
vivo
elispot
assay
intracellular
cytokin
stain
ic
irradi
autolog
b
cell
line
bcl
use
present
hcmv
peptid
epitop
peptid
pool
hcmv
tissu
cell
supplementari
tabl
compar
infect
like
induc
cell
respons
hlaa
hlab
peptid
epitop
bltl
mice
fig
supplementari
tabl
strain
also
consist
induc
cell
respons
hcmv
earli
day
postexposur
fig
g
supplementari
tabl
immunopreval
hcmv
protein
found
virion
express
detect
respons
consist
vivo
lytic
replic
hcmv
observ
fig
hcmvspecif
cell
respons
detect
human
lung
implant
bltl
mice
system
liver
mous
lung
fig
maintain
day
last
time
point
analyz
fig
supplementari
tabl
full
detail
cell
reactiv
provid
supplementari
tabl
data
demonstr
cell
respons
bltl
mice
progress
declin
activ
indic
mice
product
infect
hcmv
unlik
lom
fig
fig
supplementari
fig
viru
replic
control
hcmvdna
readili
detect
human
lung
implant
bltl
mice
analyz
day
post
exposur
supplementari
tabl
howev
consist
immunemedi
virolog
control
observ
bltl
mice
fig
human
lung
implant
analyz
day
postexposur
none
human
lung
implant
analyz
day
postexposur
detect
level
viral
dna
supplementari
tabl
hcmvdna
rare
detect
tissu
analyz
supplementari
tabl
suggest
hcmv
dissemin
peripher
tissu
limit
andor
replic
control
mimic
ongo
antigen
exposur
occur
chronic
hcmv
infect
investig
effect
repeat
hcmv
exposur
host
immun
respons
mice
inocul
dose
hcmv
mice
detect
hcmvspecif
igm
follow
repeat
hcmv
exposur
regardless
infect
hcmv
strain
fig
hcmvspecif
igg
detect
reexpos
bltl
mice
fig
demonstr
effici
class
switch
plasma
sampl
collect
bltl
mice
repeatedli
expos
detect
hcmvspecif
igm
igg
possess
neutral
activ
reduc
hcmv
infect
vitro
supplementari
fig
time
first
hcmv
exposur
antibodi
test
differ
singli
multipli
expos
mice
dose
mean
day
postexposur
rang
day
dose
mean
day
postexposur
rang
day
therefor
exclud
time
addit
repeat
antigen
exposur
contribut
class
switch
howev
fail
induc
hcmvspecif
igg
day
singl
exposur
fig
supplementari
tabl
despit
presenc
detect
hcmvspecif
cell
respons
fig
hcmv
infect
induc
robust
sustain
cell
bltl
mice
inocul
hcmv
unabl
detect
hcmvspecif
cell
respons
ic
data
shown
howev
follow
repeat
hcmv
exposur
cell
cytokin
respons
detect
human
lung
implant
liver
bltl
mice
suggest
repeat
antigen
exposur
induc
augment
antigenspecif
cell
respons
fig
cell
respons
measur
ic
detect
frequent
repeatedli
hcmv
expos
mice
singli
expos
bltl
mice
fischer
exact
twotail
fig
e
supplementari
tabl
repeat
hcmv
exposur
also
induc
stronger
hcmvspecif
cell
respons
across
tissu
fig
fig
produc
cell
respons
consist
report
chronic
human
hcmv
increas
pentam
reactiv
also
observ
classic
restrict
hcmvspecif
cell
repeat
exposur
bltl
mice
approach
cell
fig
greater
pentam
frequenc
observ
follow
singl
exposur
fig
data
shown
full
detail
immun
reactiv
follow
repeat
hcmv
inocul
provid
supplementari
tabl
although
bltl
mice
expos
multipl
dose
hcmvdna
detect
human
lung
implant
mice
analyz
expos
bltl
mice
supplementari
tabl
hcmvdna
rare
detect
tissu
human
lung
implant
tissu
analyz
detect
pb
supplementari
tabl
suggest
strong
immun
control
hcmv
replic
vivo
extend
breadth
human
pathogen
studi
use
human
mice
valid
two
novel
model
lom
bltl
mice
provid
human
lung
tissu
vivo
target
human
pathogen
either
without
lom
bltl
mice
autolog
system
human
immun
system
engraft
level
human
immun
cell
type
bltl
mice
similar
previous
report
blt
subcutan
implant
human
lung
tissu
expand
develop
lung
implant
contain
human
epitheli
endotheli
mesenchym
cell
vasculatur
human
origin
underneath
skin
lung
implant
readili
access
imag
use
lom
demonstr
human
lung
implant
suscept
five
divers
emerg
clinic
relev
human
pathogen
merscov
zikv
mycobacteria
rsv
hcmv
without
engin
pathogen
host
howev
possibl
respir
lung
differ
host
gene
express
profil
could
alter
replic
condit
pathogen
next
demonstr
preexposur
prophylaxi
gcv
effect
control
hcmv
replic
lom
perform
vivo
transcriptom
analysi
lytic
hcmv
infect
futur
transcriptom
analys
pathogen
host
may
identifi
new
drug
target
host
factor
modul
infect
hcmv
infect
bltl
mice
produc
acut
viru
kinet
reflect
lytic
replic
consist
report
human
onset
adapt
humor
cell
respons
hcmv
replic
bltl
mice
declin
background
level
wherea
hcmvdna
detect
expos
lom
hcmvdna
detect
bltl
mice
first
two
week
post
infect
consist
strong
virolog
immun
control
observ
cell
respons
detect
lung
implant
earli
day
postinocul
multipl
epitop
includ
protein
target
human
hcmvspecif
cell
detect
system
liver
mous
lung
hcmvspecif
cell
respons
detect
day
follow
inocul
induct
system
antigenspecif
immun
respons
bltl
mice
combin
data
demonstr
product
human
cytokineschemokin
follow
ex
vivo
mitogen
stimul
human
immun
cell
isol
lung
implant
demonstr
function
human
immun
cell
repopul
lung
implant
mimick
ongo
antigen
exposur
occur
chronic
hcmv
infect
multipl
exposur
hcmv
result
robust
hcmvspecif
antibodi
cell
respons
bltl
mice
readili
detect
hcmvspecif
igg
bltl
mice
reexpos
suggest
repeat
antigen
stimul
facilit
human
igg
class
switch
multipl
hcmv
exposur
also
induc
robust
hcmvspecif
cell
respons
natur
hcmv
infect
human
elicit
lifelong
cell
respons
high
reactiv
readili
observ
specif
cell
multipl
tissu
bltl
mice
repeatedli
expos
hcmv
magnitud
hcmvspecif
cell
respons
also
increas
bltl
mice
expos
multipl
dose
hcmv
reach
level
compar
fact
repeat
exposur
use
broaden
immunopreval
cell
respons
bltl
mice
suggest
model
might
use
vaccin
test
observ
hcmvspecif
cell
respons
hcmvspecif
igg
cohort
f
bltl
mice
despit
multipl
exposur
cohort
f
homozyg
across
class
ia
ii
allel
supplementari
tabl
hcmv
induc
low
level
igm
class
switch
observ
fig
b
squar
symbol
despit
day
followup
post
first
hcmv
exposur
cell
respons
detect
fig
supplementari
tabl
cell
mdc
cohort
function
specif
mitogen
stimul
cell
induc
potent
cytokin
product
degranul
autolog
mdc
induc
mixedlymphocyt
reaction
mlr
cocultur
allogen
pbmc
data
shown
result
suggest
limit
repertoir
hla
present
viral
peptid
imped
gener
antigenspecif
adapt
immun
respons
vivo
bltl
mice
gener
antigenspecif
humor
cellmedi
immun
respons
control
pathogen
replic
vivo
result
valid
bltl
mice
vivo
platform
studi
replic
pathogenesi
immunogen
human
pathogen
context
function
system
human
immun
system
regard
bltl
mice
would
support
type
direct
systemat
sophist
vivo
experiment
characterist
rodent
model
perform
human
result
also
support
bltl
mice
model
vivo
evalu
human
immun
therapi
includ
vaccin
especi
diseas
strict
speci
tropism
summari
develop
two
novel
human
mous
model
support
infect
replic
import
human
viral
bacteri
pathogen
lom
bltl
mice
could
use
studi
human
pathogen
target
lung
eg
enteroviru
adenoviru
type
influenza
viru
rhinoviru
metapneumoviru
acceler
vivo
test
prevent
therepeut
approach
agent
analysi
implant
vascular
use
ultrasound
acoust
angiographi
noninvas
techniqu
visual
microvasculatur
also
suggest
technolog
use
monitor
angiogenesi
vascular
system
result
also
suggest
develop
addit
vivo
human
mous
model
human
pathogen
tropism
tissu
might
possibl
enhanc
precis
human
mous
model
biomed
research
anim
studi
carri
accord
protocol
approv
institut
use
care
committe
uncchapel
hill
adher
nih
guid
care
use
laboratori
anim
lungonli
mice
lom
construct
implant
two
piec
human
fetal
lung
tissu
advanc
bioscienc
resourc
alameda
ca
subcutan
back
right
left
back
upper
lower
back
week
old
male
femal
nodcgprkdcscid
mice
nsg
jackson
laboratori
bar
harbor
mice
creat
two
separ
human
lung
implant
engraft
expans
human
lung
implant
monitor
palpat
week
post
implant
lung
implant
readili
palpabl
skin
mice
easi
manipul
experi
lung
implant
persist
least
month
post
implant
last
time
point
analyz
bltlung
bltl
mice
construct
implant
sandwich
human
fetal
thymusliverthymu
tissu
advanc
bioscienc
resourc
alameda
ca
kidney
capsul
irradi
rad
week
old
male
femal
nsg
mice
two
piec
autolog
human
lung
tissu
implant
subcutan
right
left
back
follow
tissu
implant
anim
receiv
bone
marrow
transplant
via
tail
vein
inject
autolog
liverderiv
human
hematopoiet
stem
cell
cell
fraction
use
hla
type
hlaa
b
c
loci
reconstitut
bltl
mice
human
hematopoeit
cell
monitor
longitudin
flow
cytometri
previous
mice
maintain
divis
compar
medicin
uncchapel
hill
two
form
ultrasound
imag
use
vevo
version
visualson
inc
acquisit
softwar
perform
bmode
sensit
differ
tissu
type
acoust
angiographi
sensit
microvasculatur
bmode
imag
use
assess
implant
volum
acoust
angiographi
perform
visual
implant
vasculatur
acoust
angiographi
describ
detail
imag
lom
mice
human
lung
implant
week
postsurgeri
anesthet
vapor
isofluran
maintain
anim
side
back
depil
hair
remov
cream
nair
ultrasound
transduc
coupl
skin
gel
acoust
angiographi
imag
microbubbl
contrast
agent
mca
dilut
salin
administ
intraven
tailvein
cathet
lipidshel
perfluorocarbon
core
mca
use
standard
ultrasound
imag
describ
applic
render
perform
slicer
version
imag
process
analys
perform
matlab
version
mathwork
inc
implant
volum
measur
bmode
ultrasound
imag
follow
first
center
slice
implant
identifi
three
orthogon
plane
dimens
implant
measur
central
slice
result
two
measur
dimens
two
independ
measur
averag
obtain
three
orthogon
dimens
ie
diamet
implant
implant
volum
approxim
ellipsoid
size
given
b
c
equal
one
half
orthogon
dimens
measur
immunohistochem
analys
perform
previous
briefli
human
lung
tissu
tissu
collect
nsg
lom
bltl
mice
fix
pfa
formalin
paraffin
embed
cut
section
prior
primari
antibodi
incub
antigen
retriev
perform
igbind
site
endogen
peroxidas
activ
block
tissu
section
develop
use
polym
system
biocar
medic
dab
vector
laboratori
counterstain
hematoxylin
mount
immunofluoresc
stain
also
perform
pfa
formalin
fix
paraffin
embed
tissu
section
follow
antigen
retriev
block
serum
correspond
secondari
antibodi
host
speci
triton
rodent
block
biocar
medic
pb
tissu
section
incub
primari
antibodi
overnight
tissu
section
stain
fluoresc
conjug
secondari
antibodi
follow
dapi
mount
primari
antibodi
direct
human
epitheli
cell
cytokeratin
endotheli
cell
mesenchym
cell
vimentin
hematopoiet
cell
macrophag
dendrit
cell
natur
killer
nk
cellsnk
cell
b
cell
cell
cell
cell
life
scienc
report
summari
primari
antibodi
direct
mous
endotheli
cell
epitheli
cell
mcytokeratin
hematopoiet
cell
use
distinguish
presenc
mous
cell
life
scienc
report
summari
primari
antibodi
direct
hcmv
glycoprotein
b
immedi
earli
ie
earli
e
late
l
protein
use
detect
hcmv
posit
cell
life
scienc
report
summari
tissu
section
stain
antizikv
antibodi
detect
zikv
infect
cell
small
piec
human
lung
implant
tissu
collect
merscov
infect
lom
fix
formalin
day
embed
paraffin
section
stain
merscov
nucleocapsid
polyclon
antibodi
life
scienc
report
summari
tissu
section
also
stain
appropri
isotyp
neg
control
antibodi
tissu
section
immunohistochemistri
imag
nikon
eclips
ci
microscop
use
nikon
element
br
softwar
version
nikon
digit
sight
camera
bright
contrast
adjust
whole
imag
adob
photoshop
tissu
section
immunofluoresc
imag
olympu
upright
wide
field
microscop
use
improvis
veloc
softwar
version
x
hammatus
orca
rc
camera
bright
contrast
adjust
whole
imag
use
imagej
softwar
version
fig
h
pseudocolor
use
depict
merscov
zikv
rsv
hcmv
antigen
green
human
cell
type
magenta
fig
j
fig
supplementari
fig
redgreen
fluoresc
imag
origin
captur
red
fluoresc
signal
digit
alter
improv
visual
colorblind
reader
adjust
red
channel
hue
use
adob
photoshop
human
immun
cell
reconstitut
peripher
blood
pb
tissu
bltl
mice
analyz
flow
cytometri
mnc
isol
tissu
collect
bltl
mice
passag
cell
strainer
red
blood
cell
rbc
lysi
previous
human
lung
implant
mous
lung
liver
femal
reproduct
tract
enzymat
digest
prior
pass
tissu
cell
strainer
liver
mous
lung
mnc
purifi
percol
gradient
mnc
isol
gastrointestin
tract
small
larg
intestin
lamina
propria
layer
enzymat
digest
previous
describ
prior
antibodi
life
scienc
report
summari
incub
igbind
site
block
antibodi
panel
follow
panel
panel
panel
neg
control
mous
neg
control
mous
neg
control
rat
hladrpercp
neg
control
mous
neg
control
mous
panel
blue
neg
control
mous
blue
neg
control
mous
hladrpercp
neg
control
mous
neg
control
mous
panel
follow
antibodi
incub
pb
treat
bd
fac
lyse
solut
bd
bioscienc
remov
rbc
sampl
wash
fix
pfa
data
acquir
bd
lsrfortessa
facscanto
instrument
analyz
facsdiva
softwar
version
mnc
isol
bltl
mous
mice
lung
implant
repres
two
experi
human
lung
implant
human
lung
implant
enzymat
digest
prior
pass
tissu
cell
strainer
mnc
purifi
percol
gradient
mnc
pool
lung
implant
mice
lung
implant
cultur
cellswel
well
plate
h
rpmi
supplement
fb
penicillinstreptomycin
untreat
control
well
per
experi
media
supplement
pma
ngml
ionomycin
ngml
well
experi
well
experi
lp
ngml
e
coli
sigma
well
per
experi
cell
cultur
supernat
collect
h
cell
also
isol
human
lung
implant
lom
mous
human
lung
implant
repres
one
experi
follow
h
enzymat
digest
proteas
dnase
solut
dilut
media
supplement
amphotericin
gentamicin
cell
cell
per
well
cultur
overnight
bronchial
epitheli
growth
medium
begm
supplement
fb
well
collagen
coat
well
plate
human
placent
collagen
type
iv
well
wash
remov
nonadher
cell
cell
cultur
begm
fb
media
alon
untreat
control
supplement
lp
ngml
e
coli
sigma
well
per
conditionlung
implant
cell
cultur
supernat
collect
h
plasma
isol
pb
collect
bltl
mice
mice
repres
three
experi
day
prior
day
post
inocul
human
lung
implant
human
cytokinechemokin
level
cell
cultur
supernat
plasma
measur
use
milliplex
map
kit
millipor
limit
detect
pgml
luminex
magpix
instrument
sampl
run
undilut
singular
well
follow
human
analyt
measur
ligand
fractalkin
gcsf
gmcsf
gro
mdc
pdgfaa
pdgfabbb
rant
vegf
egf
begm
contain
human
egf
therefor
egf
level
report
stock
wildtyp
merscov
origin
provid
dr
bart
haagman
erasmu
medic
center
rotterdam
netherland
passag
prepar
viru
titer
determin
vero
cell
atcc
biosafeti
level
bsl
condit
previous
merscov
pfu
per
human
lung
implant
inocul
human
lung
implant
anesthet
lom
via
direct
inject
volum
human
lung
implant
harvest
h
postinfect
pfu
mice
human
lung
implant
repres
one
experi
pfu
mice
human
lung
implant
repres
two
experi
determin
tissu
merscov
titer
piec
human
lung
implant
weigh
homogen
store
stock
zika
viru
zikv
strain
prepar
vero
cell
atcc
viru
titer
determin
quantifi
number
zikvrna
copi
realtim
pcr
zikvrna
copiesffu
base
realtim
pcr
analysi
zikv
stock
titer
vero
cell
previous
describ
human
lung
implant
lom
inject
ffu
zikv
lom
human
lung
implant
per
dose
repres
one
experi
volum
per
implant
mice
necropsi
h
postinocul
human
lung
implant
process
singl
cell
suspens
describ
cellassoci
zikvrna
level
measur
use
quantit
realtim
pcr
assay
use
rna
toct
kit
appli
biosystem
sequenc
forward
revers
primer
probe
pcr
amplif
detect
zikv
rna
mycobacterium
bovi
bacillu
bcg
pasteur
grown
c
liquid
middlebrook
medium
supplement
tween
glycerol
ad
bovin
serum
albumin
glucos
nacl
human
lung
implant
anesthet
lom
inject
cfu
bcg
lom
human
lung
implant
per
dose
repres
one
experi
volum
per
lung
implant
mice
necropsi
day
postexposur
necropsi
onehalf
human
lung
implant
homogen
pb
supplement
tween
ngml
cycloheximid
carbenicillin
dilut
homogen
plate
onto
plate
mgml
cycloheximid
cfu
enumer
total
number
cfu
per
human
lung
implant
calcul
multipli
number
cfu
visual
bcg
lom
inject
cfu
bcg
via
intrahuman
lung
inject
volum
necropsi
day
postexposur
small
piec
human
lung
implant
tissu
fix
pfa
paraffin
embed
section
ziehlneelsen
acidfast
stain
perform
carbol
fuchsin
methylen
blue
tissu
section
imag
olympu
microscop
retiga
camera
bright
contrast
adjust
adob
photoshop
recombin
rsv
strain
express
gfp
previous
rsv
tciu
per
human
lung
implant
directli
inject
volum
human
lung
implant
anesthet
lom
mice
human
lung
implant
repres
two
experi
necropsi
day
postexposur
human
lung
implant
harvest
enzymat
digest
pass
cell
strainer
rsv
infect
replic
evalu
measur
gfp
express
flow
cytometri
data
collect
bd
lsrfortessa
instrument
analyz
bd
facsdiva
softwar
version
immunofluores
paraffinembed
tissu
section
probe
antirsv
antibodi
anticytokeratin
antibodi
iv
antibodi
life
scienc
report
summari
detect
cilia
ciliat
cell
club
cell
detect
antibodi
alcianblu
period
acidschiff
abpa
stain
peform
analyz
mucu
product
human
lung
implant
naiv
control
rsvinfect
lom
section
imag
olympu
upright
wide
field
microscop
hammatus
orca
rc
camera
olympu
virtual
slide
scan
system
alli
vision
pike
ccd
progress
scan
camera
leica
dm
irb
epifluoresc
microscop
qimag
retiga
camera
imag
acquisit
perform
use
improvis
voloc
version
qimag
q
captur
softwar
version
brightnesscontrast
adjust
whole
imag
use
imagej
softwar
version
anesthet
lom
bltl
mice
expos
hcmv
direct
inject
hcmv
human
lung
implant
time
cours
experi
lom
human
lung
implant
harvest
day
n
mice
human
lung
implant
n
mice
human
lung
oganoid
mice
human
lung
implant
mice
human
lung
implant
postexposur
repres
one
experi
infect
human
lung
implant
analyz
day
postexposur
fig
repres
addit
lom
gcv
preexposur
prophylaxi
experi
lom
mice
human
lung
implant
administ
mgkg
gcv
daili
day
intraperiton
inject
inocul
hcmv
express
luciferas
two
gvc
dose
untreat
lom
mice
human
lung
implant
inocul
hcmv
express
luciferas
serv
control
luciferas
express
measur
anesthet
mice
ivi
lumina
optic
system
follow
intraperiton
inject
dluciferin
mgkg
day
postexposur
time
cours
experi
lom
human
lung
implant
harvest
day
n
mice
human
lung
implant
n
mice
human
lung
oganoid
mice
human
lung
implaesthet
lom
bltl
mice
expos
nt
mice
human
lung
implant
mice
human
lung
implant
postexposur
repres
one
experi
evalu
hcmv
replic
time
human
lung
implant
hcmv
express
luciferas
inocul
human
lung
implant
human
donor
match
lom
mice
human
lung
implant
bltl
mice
mice
human
lung
implant
luciferas
express
measur
anesthet
mice
ivi
lumina
optic
system
follow
intraperiton
inject
dluciferin
mgkg
day
week
follow
hcmv
exposur
baselin
luminesc
human
lung
implant
determin
lom
bltl
mice
prior
hcmv
exposur
data
repres
one
experi
lom
bltl
mice
evalu
hcmvspecif
immun
respons
multipl
viru
dose
bltl
mice
receiv
three
administ
one
month
two
week
apart
four
administ
two
week
apart
inocul
hcmv
pb
tissu
collect
lom
bltl
mice
process
describ
previous
fig
human
lung
implant
cell
isol
infect
lom
also
percol
hcmvdna
level
peripher
blood
tissu
cell
measur
realtim
pcr
analysi
previous
data
repres
five
experi
total
rna
extract
human
lung
implant
harvest
hcmv
infect
lom
use
trizol
follow
tissu
homogen
combin
data
repres
one
experi
ribosom
rna
rrna
deplet
use
thermo
fisher
doublestrand
cdna
ds
cdna
gener
rrnadeplet
total
rna
use
smarter
pcr
cdna
synthesi
kit
takara
viralspecif
ds
cdna
captur
use
custom
design
biotinyl
probe
span
strand
entir
hcmv
genom
agil
extens
wash
bound
ds
cdna
elut
captur
probe
next
gener
sequenc
ng
librari
gener
elut
ds
cdna
use
nextera
xt
transfragment
kit
illumina
result
librari
sequenc
illumina
hiseq
use
bp
pair
end
read
high
qualiti
read
align
hcmv
genom
viral
express
quantifi
read
per
kilobas
per
million
rpkm
use
cuffdiff
cufflink
version
antibodi
hcmv
plasma
measur
use
either
hcmv
igm
igg
enzym
immunoassay
test
kit
genway
ca
usa
hcmv
igm
igg
index
averag
od
triplic
sampl
calibr
od
lot
specif
calibr
factor
per
manufactur
protocol
randomli
select
sampl
rerun
assess
intraassay
variabl
test
show
low
inter
intraassay
variabl
cv
seroposit
sampl
design
either
hcmv
igm
igg
index
measur
index
bltl
mice
analyz
hcmv
neutral
activ
plasma
hcmvexpos
bltl
mice
plasma
bltl
mous
bltl
mice
expos
repeatedli
mice
heat
min
dilut
media
supplement
fb
heatinactiv
penicillinstreptomycin
dilut
plasma
incub
h
viru
mixtur
ad
cell
moi
quadrupl
well
well
plate
incub
h
time
viru
contain
media
remov
fresh
media
ad
h
cell
fix
stain
dapi
number
rfp
cell
count
data
repres
one
vitro
infect
experi
autolog
human
blymphoblastoid
cell
line
blcl
myeloid
dendrit
cell
mdc
gener
human
tissu
donor
analyz
eight
donor
total
use
antigen
present
cell
apc
elispot
ic
assay
blcl
deriv
human
fetal
liver
fraction
human
cell
posit
select
bltl
tissu
cell
use
microbead
miltenyi
follow
manufactur
instruct
cell
infect
ebv
overnight
maintain
c
transform
week
later
blcl
propag
rpmi
fb
mdc
gener
human
fetal
liverderiv
cell
magnet
select
use
microbead
miltenyi
purifi
plate
concentr
cellsml
imdm
medium
supplement
fb
ngml
gmcsf
ngml
ngml
ngml
scf
ngml
r
system
medium
refresh
everi
day
matur
dc
initi
three
day
plan
cell
assay
use
imdm
supplement
fb
uml
gmcsf
ngml
ngml
uml
ngml
r
system
autolog
blcl
posit
mdc
posit
phenotyp
flow
cytometri
use
follow
antibodi
panhlai
classpacif
blue
hlaep
life
scienc
report
summari
apc
irradi
peptid
puls
peptid
synthes
sigmagenosi
autolog
blcl
matur
mdc
irradi
rad
puls
min
c
either
individu
peptid
pool
overlap
peptid
aa
overlap
span
cmv
protein
peptid
cell
wash
count
ad
cell
assay
follow
individu
peptid
use
studi
includ
nlvpmvatv
ipsinvhhi
b
bltl
tissu
cell
cocultur
peptidepuls
autolog
blcl
ratio
h
assay
perform
triplic
quadrupl
tissu
cell
cocultur
mockpuls
blcl
serv
neg
control
tissu
cell
cocultur
ngml
pma
ngml
ionomycin
serv
posit
control
elispot
assay
develop
spot
count
perform
describ
elispot
data
express
mean
spot
form
unit
sfu
per
million
cell
sem
posit
cell
respons
defin
sfumillion
cell
mean
neg
control
well
criteria
posit
across
assay
cohort
averag
mockpuls
blcl
sfuinput
cell
detail
supplementari
tabl
peptidepuls
autolog
blcl
mdc
irradi
rad
combin
filter
total
miltenyi
select
tissu
suspens
minimum
cell
panel
measur
either
measur
cocultur
immedi
stain
monensin
ad
cultur
h
overnight
next
cell
stain
zombi
nir
viabil
dye
rt
min
label
percpconjug
dump
channel
rt
min
cell
fix
permeabil
stain
intracellularli
either
detect
monensinbrefeldin
ad
cocultur
incub
overnight
next
day
cell
stain
zombi
nir
lymphocyt
marker
describ
cell
fix
permeabil
stain
intracellularli
life
scienc
report
summari
assay
fluoresc
minu
one
fmo
control
use
gate
cytokin
reactiv
popul
compens
bead
use
color
except
zombi
zombi
live
dead
heat
inactiv
cell
mix
zombi
stain
gener
posit
neg
popul
cell
acquir
use
lsrfortessa
flow
cytomet
data
analyz
flowjo
softwar
version
gate
strategi
illustr
supplementari
figur
b
cell
respons
express
frequenc
either
cell
lymphocyt
hcmvspecif
cell
respons
met
follow
criteria
posit
event
cell
minimum
event
doubleposit
gate
nopeptid
control
pe
apcconjug
pentam
proimmun
use
stain
total
miltenyi
biotec
select
tissu
liver
orand
human
lung
suspens
assay
minimum
cell
use
cell
filter
prior
stain
cell
stain
zombi
viabil
dye
rt
min
follow
stain
pentam
per
manufactur
instruct
rt
min
wash
percpconjug
dump
channel
ad
cell
incub
ice
min
cell
wash
fix
cell
acquir
use
lsrfortessa
flow
cytomet
data
analyz
flowjo
softwar
version
gate
strategi
illustr
supplementari
fig
pentam
reactiv
popul
met
follow
criteria
posit
event
greater
control
pentam
hlamismatch
nonhcmv
greater
cell
event
pentam
gate
evid
nonspecif
stain
cell
gate
statist
test
use
indic
figur
legend
andor
result
definit
center
dispers
precis
measur
indic
figur
legend
andor
result
exact
valu
n
n
stand
figur
legend
method
detail
statist
analys
perform
graphpad
prism
version
r
version
statist
method
use
predetermin
sampl
size
random
use
determin
samplesanim
alloc
experiment
group
process
investig
blind
group
alloc
assess
outcom
statist
comparison
p
valu
consid
signific
statist
test
exact
twotail
mannwhitney
test
use
compar
luciferas
activ
human
lung
implant
lom
bltl
mice
fig
human
immun
cell
level
mous
lung
human
lung
organoid
bltl
mice
supplementari
twotail
fischer
exact
test
use
compar
incid
hcmvspecif
human
igm
igg
cell
bltl
mice
expos
one
multipl
dose
hcmv
fig
human
cytokin
chemokin
level
pre
post
hcmv
inocul
compar
twotail
wilcoxon
matchedpair
sign
rank
test
supplementari
fig
